As per the research report, the size of the Europe Cannula Market is valued at USD 39.16 billion in 2019 and estimated to be growing at a CAGR of 5.77%, to reach USD 51.84 billion by 2024 during the forecast period 2019-2024.
Cannula is a tube which is inserted into the body for purposes such as injection of fluid, removal of fluid and collection of data. A cannula can cover the inner and outer layers of a trocar needle, thus increasing the effective length of the needle by about half the original length of the needle.
In veterinary applications, it is used to relieve cattle from bloating and pressure in abdomen which is most commonly caused by the accidental consumption of legume. They are also used in the insertion of verichip. In aesthetic medicine, it finds its application in the form of blunt-tip cannula which has a small tube with an edge which is used for subdermal injection of gels or fluids. It is also used in liposuction procedures for injecting cosmetic wrinkle filters like collagen and hyaluronic acid. A push-pull cannula which can both inject and withdraw fluid is used to study the effects of different chemicals on a cell.
The driving factors of Europe Cannula market are advancements in healthcare facilities, rising number of surgeries, large number of patients, growing investment in research and development, rising investments by government and growing number of minimally invasive procedures among others. However, the market is constrained by factors like uncertain frameworks in regulations.
This research report segmented and sub-segmented into the following categories:
Europe has the second largest market for cannula in the world by share. Factors such as rising number of surgical procedures and large number of patients is expected to drive the market growth in the region.
Key players operating in the Europe Cannula Market profiled in this report are Medtronic plc (U.S.), Edward Lifesciences Corp. (U.S.), Terumo Corporation (Japan), Sorin Group (Italy), and Maquet Holding B.V. & Co. KG (Germany) among others.
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Application
5.1.1 Oxygen Therapy
5.1.2 General Surgery
5.1.3 Cardiovascular Surgery
5.1.4 Plastic Surgery
5.1.5 Orthopaedic Surgery
5.1.6 Other Applications
5.1.7 Y-o-Y Growth Analysis, By Application
5.1.8 Market Attractiveness Analysis, By Application
5.1.9 Market Share Analysis, By Application
5.2 Product
5.2.1 Vascular Cannulas
5.2.2 Cardiac Cannulas
5.2.3 Arthoscopy Cannulas
5.2.4 Nasal Cannulas
5.2.5 Dermatology Cannulas
5.2.6 Other Products
5.2.7 Y-o-Y Growth Analysis, By Product
5.2.8 Market Attractiveness Analysis, By Product
5.2.9 Market Share Analysis, By Product
5.3 Material
5.3.1 Metal
5.3.2 Silicone
5.3.3 Plastic
5.3.4 Y-o-Y Growth Analysis, By Material
5.3.5 Market Attractiveness Analysis, By Material
5.3.6 Market Share Analysis, By Material
5.4 End Users
5.4.1 Hospitals
5.4.2 Ambulatory Surgical Centres
5.4.3 Other End Users
5.4.4 Y-o-Y Growth Analysis, By End Users
5.4.5 Market Attractiveness Analysis, By End Users
5.4.6 Market Share Analysis, By End Users
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Application
6.1.3.2 By Product
6.1.3.3 By Material
6.1.3.4 By End Users
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Application
6.1.4.2 By Product
6.1.4.3 By Material
6.1.4.4 By End Users
6.1.5 Market Share Analysis
6.1.5.1 By Application
6.1.5.2 By Product
6.1.5.3 By Material
6.1.5.4 By End Users
6.2 U.K
6.3 Spain
6.4 Germany
6.5 Italy
6.6 France
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Medtronic plc
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Edward Lifesciences Corp.
8.3 Terumo Corporation
8.4 Sorin Group
8.5 Maquet Holding B.V. & Co. KG
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
